Concepedia

Ifosfamide in pediatric malignant solid tumors

C B Pratt, E C Douglass, Erlinda Etcubanas, Marshall P. Goren, A. A. Green, F. Ann Hayes, Marc E. Horowitz, William H. Meyer, Elizabeth I. Thompson, Judith A. Wilimas

Cancer Chemotherapy and Pharmacology · 1989 · 43 citations · 23 references

DOI

Concepts

References

23

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Martin M. Oken, Richard H. Creech, Douglass C. Tormey et al. · American Journal of Clinical Oncology · 1982 · 11.6K citations

, , +8

Cyclophosphamide cystitis—Identification of acrolein as the causative agent

Peter J. Cox · Biochemical Pharmacology · 1979 · 575 citations

, , +5

Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.

J. Miser, Timothy J. Kinsella, Timothy J. Triche et al. · Journal of Clinical Oncology · 1987 · 324 citations

, , +17

Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomas

Vivien Bramwell, Henning T. Mouridsen, Armando Santoro et al. · European Journal of Cancer and Clinical Oncology · 1987 · 243 citations

, , +8

Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.

N Brock, Jurij Stekar, J. Pohl et al. · PubMed · 1979 · 187 citations

, , +11